chr1-159171815-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001127173.3(CADM3):c.50G>A(p.Cys17Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000233 in 1,247,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000024 ( 0 hom. )
Consequence
CADM3
NM_001127173.3 missense
NM_001127173.3 missense
Scores
3
3
13
Clinical Significance
Conservation
PhyloP100: 4.35
Genes affected
CADM3 (HGNC:17601): (cell adhesion molecule 3) The protein encoded by this gene is a calcium-independent cell-cell adhesion protein that can form homodimers or heterodimers with other nectin proteins. The encoded protein has both homophilic and heterophilic cell-cell adhesion activity. This gene is reported to be a tumor suppressor gene. [provided by RefSeq, Oct 2016]
AIM2 (HGNC:357): (absent in melanoma 2) AIM2 is a member of the IFI20X /IFI16 family. It plays a putative role in tumorigenic reversion and may control cell proliferation. Interferon-gamma induces expression of AIM2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.16410887).
BS2
High AC in GnomAdExome4 at 26 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CADM3 | NM_001127173.3 | c.50G>A | p.Cys17Tyr | missense_variant | 1/9 | ENST00000368125.9 | NP_001120645.1 | |
CADM3 | NM_021189.5 | c.50G>A | p.Cys17Tyr | missense_variant | 1/10 | NP_067012.1 | ||
CADM3 | NM_001346510.2 | c.50G>A | p.Cys17Tyr | missense_variant | 1/9 | NP_001333439.1 | ||
CADM3 | XM_024448760.2 | c.50G>A | p.Cys17Tyr | missense_variant | 1/12 | XP_024304528.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CADM3 | ENST00000368125.9 | c.50G>A | p.Cys17Tyr | missense_variant | 1/9 | 1 | NM_001127173.3 | ENSP00000357107 | P2 | |
CADM3 | ENST00000368124.8 | c.50G>A | p.Cys17Tyr | missense_variant | 1/10 | 1 | ENSP00000357106 | A2 | ||
CADM3 | ENST00000416746.1 | c.50G>A | p.Cys17Tyr | missense_variant | 1/7 | 1 | ENSP00000387802 | |||
AIM2 | ENST00000695582.1 | n.33+15996C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152136Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
3
AN:
152136
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000114 AC: 2AN: 17486Hom.: 0 AF XY: 0.000198 AC XY: 2AN XY: 10082
GnomAD3 exomes
AF:
AC:
2
AN:
17486
Hom.:
AF XY:
AC XY:
2
AN XY:
10082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000237 AC: 26AN: 1094922Hom.: 0 Cov.: 31 AF XY: 0.0000328 AC XY: 17AN XY: 518526
GnomAD4 exome
AF:
AC:
26
AN:
1094922
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
518526
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152136Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74322
GnomAD4 genome
AF:
AC:
3
AN:
152136
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.50G>A (p.C17Y) alteration is located in exon 1 (coding exon 1) of the CADM3 gene. This alteration results from a G to A substitution at nucleotide position 50, causing the cysteine (C) at amino acid position 17 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
MutationTaster
Benign
N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Pathogenic
D;T;D
Sift4G
Pathogenic
D;T;T
Polyphen
P;P;.
Vest4
MutPred
Gain of catalytic residue at P21 (P = 0.0908);Gain of catalytic residue at P21 (P = 0.0908);Gain of catalytic residue at P21 (P = 0.0908);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at